Using CRISPR gene-editing to speed the preclinical pipeline

Since 2012, CRISPR has brought new methods to the research community to improve the accuracy and speed of preclinical development phase, and it is increasingly being adopted to accelerate the drug pipeline. With the increasing use of CRISPR to speed the drug pipeline, outsourcing can provide a more flexible supply of services with improved timelines. This application note from Abcam provides an overview of the CRISPR gene-editing timeline.